Retrieve available abstracts of 10 articles: HTML format
Single Articles
April 2025
WATTS GF, Hegele RA, Leeper NJ Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk. Reply.
N Engl J Med. 2025;392:1452-1453. PubMed
SHIMAZU Y Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
N Engl J Med. 2025;392:1452. PubMed
January 2025
STITZIEL NO Reducing the Risk of Pancreatitis by Inhibiting APOC3.
N Engl J Med. 2025;392:197-199. PubMed
November 2024
GONDA TA, Cahen DL, Farrell JJ Pancreatic Cysts. Reply.
N Engl J Med. 2024;391:2064. PubMed
HAMADA T, Oyama H, Nakai Y Pancreatic Cysts.
N Engl J Med. 2024;391:2063-2064. PubMed
September 2024
GONDA TA, Cahen DL, Farrell JJ Pancreatic Cysts.
N Engl J Med. 2024;391:832-843. PubMed
RUBIN EJ, Leopold J, Morrissey S NEJM at ESC - Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis
Risk.
N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMe2410905. PubMed
WATTS GF, Rosenson RS, Hegele RA, Goldberg IJ, et al Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMoa2409368. PubMedAbstract available
April 2024
STROES ESG, Alexander VJ, Karwatowska-Prokopczuk E, Hegele RA, et al Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2400201. PubMedAbstract available
February 2024
ALEXANDER VJ, Karwatowska-Prokopczuk E, Prohaska TA, Li L, et al Volanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.
N Engl J Med. 2024;390:476-477. PubMed